Zentalis Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.

About ZNTL

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. 

CEO
Kimberly L. Blackwell
CEOKimberly L. Blackwell
Employees
177
Employees177
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2014
Founded2014
Employees
177
Employees177

ZNTL Key Statistics

Market cap
1.24B
Market cap1.24B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
556.78K
Average volume556.78K
High today
$22.77
High today$22.77
Low today
$21.36
Low today$21.36
Open price
$21.50
Open price$21.50
Volume
603.51K
Volume603.51K
52 Week high
$87.19
52 Week high$87.19
52 Week low
$17.33
52 Week low$17.33

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

ZNTL Earnings

-$1.48
-$0.99
-$0.49
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.